1 in 4 US workers stay in jobs they are unsatisfied with due to fear of losing their health insurance. This recent survey shows that "job lock" is on a rise. Read all the data in the link below: https://bit.ly/4fj8a3s

Diagnosis of HR+, HR2- #BreastCancer within 3 years of giving birth may indicate a higher chance of recurrence. 🤰 Research published in npj Breast Cancer found those chances are nearly 3 times higher than others! See all the data with the link below: 🔗 https://bit.ly/4wogCVe

July is #SarcomaAwarenessMonth 💛 Read our coverage on an educational session from the 2026 @ascocancer.bsky.social Annual Meeting on AYA patients and the barriers to clinical trial enrollment and palliative care. Read our full feature: https://bit.ly/4wSkpK4

New research has found individuals with #Vitiligo have an overall reduce risk of developing skin cancer. 📉 However, the association varies by type of #SkinCancer and by race/ethnicity. Read all the data here: https://bit.ly/3T7edQ6

Omission of sentinel lymph node biopsies for women over 50 is one of the new updates made to the @ascocancer.bsky.social guidelines. Omitting SLNB from the treatment of early-stage #BreastCancer did not affect 5-year DFS. A promising step in surgical de-escalation! 📊 🔗 bit.ly/4wPWw5Y

What factors contribute to the acceptance of work in elite science journals? 📖 Research published in Science Advances found authors' geographic location, institutional prestige, and gender may affect acceptance rates. Read the data here: bit.ly/3TdOjtW #Oncology

A study in @JournalCancer of #EwingSarcoma survivors found that adding ifosfamide & etoposide (VDC/IE) vs. VDC alone does not increase late mortality or most long-term health risks. Key Finding: VDC/IE carried a higher 30-year risk for severe renal conditions🩺 https://bit.ly/4b63BqF #EWS

🆕 Dr Shawn Seibert of Illinois Cancercare sits down with Kimberly Ku in a new episode of Val-You Based Care! In this episode, they discuss how private and public partnerships can play a role in scaling care without sacrificing quality. Full video and transcript: https://bit.ly/3Rotz1R

68% of caregivers of children with #PediatricCancer worried about paying large cancer related medical bills❤️‍🩹 A survey from the Nebraska Medicine & Children’s Hospital & Medical Center showed financial hardship is all too common; read the study breakdown here: 🔗 https://bit.ly/4pnEsOh

It's #SarcomaAwarenessMonth 🎗️ Sarcoma is a rare cancer accounting for 1% of adult and 15% of pediatric cancer cases. This year's #ASCO26 Conference explored treatment options for sarcomas, including GIST, chondrosarcoma, and more. 🔗 See the research: https://bit.ly/4fDwg92

Last month our advisory board member, Rahul Banerjee, MD, attended #EHA2026 Dr Banerjee is a #Myeloma specialist who sat down with us after the meeting to discuss the highlights (including the MajesTEC-3 study). Watch our interview with him with the link below! 🔗 https://bit.ly/4bKe9fl

Today is #GISTAwarenessDay! 💜 Gastrointestinal Stromal Tumors are a rare form of cancer that affect the digestive system. Curious to learn more about signs and treatment options? Check out our fact sheet with the link below. 🔗 https://bit.ly/4peLEvO

ICYMI from #EHA2026 🩸 Patients who had 2 chemotherapy courses replaced with blinatumomb had a higher 4-year EFS rate than those with just chemotherapy alone. 🔗 https://bit.ly/4gmIZxT #Leukemia #LymphoblasticLeukemia

#OvarianCancer cases and deaths both declined over the past 20 years, even when accounting for women who had their ovaries removed 📉 Data from 158K+ cases reveals an annual 2.1% drop in oophorectomy-corrected incidence since 2000. 🔗 https://bit.ly/4eZxZnH

In 2006, @ascocancer.bsky.social published the first guidelines on #FertilityPreservation but factors like race/ethnicity, income, and geographic area affect whether female cancer patients receive guideline-concordant care⚕️ Read the data here: https://bit.ly/4vOXmjb

🆕 A record 49% of Americans now report they cannot access quality, affordable healthcare when they need it, according to a recent West Health-Gallup Affordability Index survey. 🚨 See the data here: 🔗 https://bit.ly/4pg7z5V

AI based tools showed promise in predicting major 30-day complications following glossectomy and reconstruction for patients with #ToungeCancer! Originally published in @jamaotolaryngology.com; find the summary here: 🔗 https://bit.ly/4vdWC6h #ArtificalIntelligence

Cervical cancer mortality is on a decline, according to research published in @jco-asco.bsky.social📉 In the 48 countries examined, 8 had more than a 50% decrease in #CervicalCancer! Inching us closer to the @who.int goal of eliminating cervical cancer by 2030! 🔗 https://bit.ly/4eOBJIB

Standardizing heart safety in cancer research! ❤️🎗️ A new @ahascience.bsky.social statement in the @jco-asco.bsky.social delivers a much-needed framework for tracking cardiovascular endpoints in oncology clinical trials. 🔗 https://bit.ly/4xVK31Z #CancerCare

Shock value wins the algorithm☀️ New research shows 87% of TikTok sunscreen videos promote SPF—but the 6% pushing myths (like SPF being "toxic") get way higher engagement. Time to level up health content! 🧴 🔗 bit.ly/4uUrBnS #SkinCancer #Melanoma

A massive new study of 1.5 million people looked at how sugary drinks vs. diet/artificially sweetened drinks impact your liver over an 18-year period. What the research found may surprise you! Check out the data here: 🔗 https://bit.ly/4eCcVn8 #LiverCancer

It's #MensHealthAwarenessMonth! Prostate cancer is the second-leading cause of cancer death in American men, but the data shows an incredibly powerful silver lining: early detection saves lives. 🩺💙 For more on current #ProstateCancer Statistics see: 🔗 https://bit.ly/4oJI2BG

🆕 Recent large-cohort data confirms that low-to-moderate alcohol intake increases all-cause mortality and morbidity, heavily driven by its status as a Group 1 carcinogen. The safest level is zero.🚫 🔗 https://bit.ly/3SIFeJf

A new secondary analysis of the INSPIRE trials shows that real-time electronic health record (CPOE) prompts can safely reduce the unnecessary use of extended-spectrum antibiotics by up to 27% for hospitalized cancer patients.📉✨ Read about the study: 🔗 https://bit.ly/4oHnx8O

📊 Shifting from opportunistic to organized population-wide #ColorectalCancer screening significantly boosts patient compliance. Countries implementing nationwide fecal test programs saw screening utilization surge by up to 46%. 🔗 See the data here: bit.ly/4b3Sgas

From #ASCO26: Teclistamab monotherapy dramatically improves survival in heavily pretreated relapsed/refractory multiple myeloma (#RRMM)! Dr Roberto Mina notes these findings support teclistamab as a new standard of care as early as the 2nd line. 🩸 🔗 https://bit.ly/4xBuhsO

Halfway through 2026 and the #Oncology world hasn't slowed down!🌍😎 From major data drops to breaking news, catch up on all of our global conference coverage so far this year: 🔗 https://bit.ly/3QQvxrD 📸 Getty Images

#Juneteenth is a celebration of freedom, resilience, and progress. But true equality must include health equity. Black Americans face a higher burden of #CancerMortality, but Black representation in global oncology trials sits at around just 3% to 8% 🔗 https://bit.ly/4xEhsOM

It's #WorldKidneyCancerDay! 🎗️🧡 Thank you to the teams of clinicians, researchers, and caretakers that make survivorship possible, and allow patients to thrive long after their final treatment!

Our advisory board member, Barbra Burtness, MD, of @yaleschoolofmed.bsky.social and @yalecancer.bsky.social, spoke with us about her top picks from this year's #ASCO26 including the KEYNOTE-412 trials 📊 To watch the full interview (with transcript), click the link below: 🔗 https://bit.ly/4ef3DP7